News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on PainChek.
RELATED STOCKHEAD STORIES
Health & Biotech
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
Health & Biotech
ASX Health Stocks: Painchek’s Europe patent accepted; and HeraMed signs deal with Telstra Health
News
Top 10 at 11: Turned-down takeovers and massive fancy diamonds are where it’s at this morning
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Who’s had their world turned upside down this week?
Health & Biotech
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
News
Rise and Shine: Everything you need to know before the ASX opens
News
CLOSING BELL: ASX sinks to -1.4pc, despite a late tech rally and some sunny Small Caps news
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?
Health & Biotech
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device
Health & Biotech
Alzheimer’s drug no longer a moonshot as race heats up, ASX-listed Actinogen in the running
Health & Biotech
ASX Health Stocks: Botanix seeks nod from US FDA; PainChek goes big in Japan
News
ASX Small Caps Lunch Wrap: Who else reckons we should kill it with fire?
Health & Biotech
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX
News
CRITERION: Investing in aged care – it never gets old
Health & Biotech